ALCAPA (#1) — Anatomy and Physiology

1) Core definition: the “wrong source” problem

Anomalous Left Coronary Artery from the Pulmonary Artery (ALCAPA) is a congenital coronary anomaly in which the left coronary artery (LCA) arises from the pulmonary artery (PA) instead of the aorta. The clinical consequence is direct: the LV myocardium (including papillary muscles) is supplied by blood that is relatively low-pressure and low-oxygen, especially after the neonatal transition. [1]

2) Why patients can look “okay” early — the postnatal transition explains the delay

ALCAPA is often postnatally unmasked by the normal fall in pulmonary vascular resistance (PVR):

• Immediately after birth (higher PVR / higher PA pressure)
• PA pressure and oxygen content are relatively higher than later infancy, so LCA perfusion may be temporarily less catastrophic. [2]
• Weeks later (PVR falls → PA pressure & oxygen content drop)
• The LCA is now connected to a low-pressure, low-oxygen reservoir, accelerating LV ischemia and dysfunction. [2]

This physiology aligns with the classic infant presentation around ~1–2 months.

3) The hallmark hemodynamic loop: collateralization → “coronary steal”

As LV ischemia progresses, compensation develops—but with a cost:

1. Collateral formation
• Collaterals develop from the right coronary artery (RCA) to the left coronary system.
2. RCA dilation / tortuosity
• The RCA becomes enlarged because it supplies both its native territory and the LV territory via collaterals. [3]
3. Runoff into the PA (“steal”)
• Because the anomalous LCA still drains into the PA, collateral-derived flow preferentially runs:

RCA → collaterals → LCA → PA

• Net effect: impressive collaterals may still fail to normalize LV perfusion because they also amplify runoff into the PA. [2,3]

4) Why mitral regurgitation is so common (and can be severe)

ALCAPA-associated MR is most often ischemic/functional rather than primarily structural:

• Papillary muscle ischemia → reduced leaflet support and poor coaptation
• LV dilation/remodeling → annular dilation and leaflet tethering
• Result: moderate-to-severe MR is frequent and can dominate the presentation. [1,4]

High-yield clinical point: infants may look like dilated cardiomyopathy (LV dilation + low EF + MR) unless ALCAPA is specifically considered. [1,12]

5) The myocardial phenotype: global ischemia with “LV failure physiology”

Because the LCA normally supplies most of the LV myocardium, ALCAPA typically produces:

• Diffuse LV ischemia (often global rather than focal in infants)
• LV systolic dysfunction → heart failure physiology
• LV dilation as a chronic response to injury
• Secondary MR → additional LV volume load, compounding failure [1,2,4]

6) Presentation patterns: infant vs older child/adult

Infants (classic presentation)

• Feeding intolerance/diaphoresis, tachypnea, irritability, poor growth
• LV dysfunction + MR; may be misdiagnosed as myocarditis/DCM
• Historically, mortality is very high without intervention. [12]

Older children/adults (survivors with robust collaterals)

• Exertional symptoms, arrhythmia, syncope, or sudden events
• Collaterals sustain life but do not eliminate ischemic risk until repaired. [12]

7) Diagnostic mindset (echo-first): “Where does the LCA originate?”

When you see infant LV dysfunction + MR, the essential question is:

“Where does the LCA originate?” [1]

Helpful echo correlates (common and highly suggestive):

• LCA flow reversal (retrograde flow toward PA)
• Collateral coronary flow
• Dilated RCA (collateral donor)
• MR and LV dysfunction as part of the same ischemic phenotype

In a multicenter echo series, frequent markers included: LCA flow reversal (91%), collateral flow (85%), and RCA dilation (81%), with MR and LV dysfunction also common. [3]

8) Why this anatomy matters clinically: the management principle

Definitive therapy is surgical restoration of a two-coronary, aortic-based system, even when symptoms are limited—because the native physiology remains intrinsically unstable. [1,6,8]

Surgical strategies (conceptual):

• Direct aortic reimplantation (preferred when anatomy allows)
• Intrapulmonary tunneling (Takeuchi repair) in selected anatomic settings

Both aim to eliminate coronary steal and re-establish physiologic coronary perfusion. [1,6]

Mitral valve question (practical evidence-based framing):

• MR is often functional and commonly improves after coronary repair alone as LV perfusion and geometry recover. [4,6]
• Concomitant mitral repair is typically reserved for clearly structural leaflet/subvalvar pathology or select severe cases where immediate competence is needed; practice is individualized. [4]

Recovery and follow-up:

• LV function frequently improves after establishing dual coronaries, though recovery may be staged over time. [5,6,9]
• Even after “normalized EF,” residual myocardial injury/arrhythmia substrate may persist—supporting lifelong congenital cardiology follow-up. [1,9]

Elicit search prompt (2 lines, in English)

“Collect and summarize clinical and mechanistic studies on ALCAPA focusing on postnatal PVR-driven physiology, RCA collateralization and coronary steal, LV ischemic remodeling, and the mechanism/trajectory of ischemic (functional) mitral regurgitation.”

“Include diagnostic imaging correlates (echo markers such as RCA dilation and retrograde LCA flow), outcomes after surgical repair (reimplantation vs Takeuchi), LV recovery time course, and evidence guiding concomitant mitral valve repair.”

References

[1] Blickenstaff EA, Smith SD, Cetta F, Connolly HM, Majdalany DS. Anomalous Left Coronary Artery from the Pulmonary Artery: How to Diagnose and Treat. J Pers Med. 2023;13(11):1561.

[2] Wesselhoeft H, Fawcett JS, Johnson AL. Anomalous origin of the left coronary artery from the pulmonary trunk. Its clinical spectrum, pathology, and pathophysiology, based on a review of 140 cases with seven further cases. Circulation. 1968;38(2):403-425.

[3] Patel SG, Frommelt MA, Frommelt PC, Kutty S, Cramer JW. Echocardiographic Diagnosis, Surgical Treatment, and Outcomes of Anomalous Left Coronary Artery from the Pulmonary Artery. J Am Soc Echocardiogr. 2017;30(9):896-903.

[4] Kudumula V, Mehta C, Stumper O, et al. Twenty-year outcome of anomalous origin of left coronary artery from pulmonary artery: management of mitral regurgitation. Ann Thorac Surg. 2014;97(3):938-944.

[5] Schwartz ML, Jonas RA, Colan SD. Anomalous origin of left coronary artery from pulmonary artery: recovery of left ventricular function after dual coronary repair. J Am Coll Cardiol. 1997;30(2):547-553.

[6] Lange R, Vogt M, Hörer J, et al. Long-term results of repair of anomalous origin of the left coronary artery from the pulmonary artery. Ann Thorac Surg. 2007;83(4):1463-1471.

[7] Kazmierczak PA, Ostrowska K, Dryżek P, Moll JA. Repair of anomalous origin of the left coronary artery from the pulmonary artery in infants. Interact Cardiovasc Thorac Surg. 2013;16(6):797-801.

[8] Zhang DY, Hao F, Zhang XW, Yan J. Mid-Term Outcome for Anomalous Origin of the Left Coronary Artery From the Pulmonary Artery. Heart Lung Circ. 2020;29(5):766-771.

[9] Cabrera AG, Chen DW, Pignatelli RH, et al. Outcomes of anomalous left coronary artery from pulmonary artery repair: beyond normal function. Ann Thorac Surg. 2015;99(4):1342-1347.

[10] Alexi-Meskishvili V, Nasseri BA, Nordmeyer S, et al. Repair of anomalous origin of the left coronary artery from the pulmonary artery in infants and children. J Thorac Cardiovasc Surg. 2011;142(4):868-874.

[11] Birk E, Stamler A, Katz A, Berant M. Anomalous origin of the left coronary artery from the pulmonary artery: diagnosis and postoperative follow up. Isr Med Assoc J. 2000;2(2):111-114.

[12] Peña E, Nguyen ET, Merchant N, Dennie G. ALCAPA syndrome: not just a pediatric disease. Radiographics. 2009;29(2):553-565.